Latest News about Biotech
Recent news which mentions Biotech
uniQure/ CSL Behring's Hemophilia Gene Therapy Shows Sustained Efficacy and Safety At Four Years
February 07, 2025
From Benzinga
Eli Lilly's Recently Approved Inflammatory Bowel Disease Drug Shows Sustained And Durable Treatment At Two Years
February 07, 2025
From Benzinga
Novo Nordisk Eyes 2025 Regulatory Filing For Hemophilia Candidate After Encouraging Pediatric Study Data
February 07, 2025
From Benzinga
Coya Therapeutics' Alzheimer's Candidate Shows Improved Inflammatory Blood Markers Following Monthly Dosing
February 06, 2025
From Benzinga
From Benzinga
Bristol Myers Squibb Warns Near-Term Impact Due To Generics On 2025 Sales Forecast, Outlines $2 Billion In Additional Cost Cuts
February 06, 2025
From Benzinga
AstraZeneca Q4 Earnings: Revenue And EPS Beat On Higher Cancer And Respiratory Drug Sales, Faces $4.5 Million Potential Fine In China
February 06, 2025
From Benzinga
Eli Lilly Q4 Earnings: Strong Demand For Mounjaro But Prices Dip, Forecasts Over 30% Jump In 2025 Sales On Newer Medicines
February 06, 2025
From Benzinga
Cannabis Takes On Superbugs: Could This New Drug 'Change Infection Treatment Forever'?
February 05, 2025
From Benzinga
What To Expect When Eli Lilly Reports Q4 Earnings On Thursday?
February 05, 2025
From Benzinga
Analysts Defend Merck Amid Investor Concerns Over Weak Guidance
February 05, 2025
From Benzinga
Amgen Impresses With Q4 Earnings Beat, Analysts See Growth Ahead
February 05, 2025
From Benzinga
GSK Q4 Earnings: Revenue And EPS Beat, Initiates $2.5 Billion Stock Buyback, Raises Long-Term Annual Sales Forecast To Over $50 Billion
February 05, 2025
From Benzinga
Novo Nordisk Q4 Earnings: Wegovy Sales More Than Double, Seeks Regulatory Approval For Hybrid Weight Loss Drug In 2026
February 05, 2025
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.